After a four‑graft coronary artery bypass graft, should I continue aspirin (81–325 mg daily) for a routine diagnostic colonoscopy?

Continue Aspirin for Routine Diagnostic Colonoscopy After CABG

Yes, continue your aspirin (81-325 mg daily) for a routine diagnostic colonoscopy, even after your four-graft CABG. Diagnostic colonoscopy with or without biopsy is classified as a low-risk endoscopic procedure, and aspirin should be continued throughout the periprocedural period to prevent life-threatening thrombotic complications 1.

Risk Stratification Framework

Low-Risk vs High-Risk Procedures

Diagnostic colonoscopy with biopsy is explicitly categorized as LOW-RISK for bleeding complications 1. The guidelines clearly distinguish this from high-risk procedures such as:

• Polypectomy (polyp removal) 1
• Endoscopic mucosal resection (EMR) 1
• Endoscopic submucosal dissection (ESD) 1
• ERCP with sphincterotomy 1
• Therapy of varices 1

For low-risk procedures, all antiplatelet agents including aspirin should be continued 1.

Your Specific Cardiac Risk Profile

After a four-graft CABG, you are at HIGH thrombotic risk due to:

• Ischaemic heart disease requiring surgical revascularization 1
• Multiple bypass grafts requiring protection 2, 3

Discontinuing aspirin in high-risk cardiac patients significantly increases the risk of:

• Acute graft thrombosis 2
• Myocardial infarction 1
• Cardiovascular death 2, 3

The British Society of Gastroenterology and European Society of Gastrointestinal Endoscopy 2021 guidelines emphasize that aspirin for secondary prevention should not be routinely stopped, and if interrupted, should be recommenced immediately once hemostasis is achieved 1.

Evidence Supporting Aspirin Continuation

For Diagnostic Procedures

The bleeding risk from diagnostic colonoscopy with biopsy on aspirin is minimal and does not justify the thrombotic risk of discontinuation 1. Multiple meta-analyses demonstrate that:

• Continuation of low-dose aspirin does not increase post-procedure bleeding after even high-risk procedures like ESD 1
• Inappropriate discontinuation of antiplatelet agents was significantly associated with increased risk of thrombosis 1
• One meta-analysis found a thrombosis rate of 2.1% in the aspirin-interrupted group versus 0% in the aspirin-continued group 1

Post-CABG Context

Aspirin is the cornerstone of antithrombotic therapy after CABG to prevent graft occlusion 2, 3. Studies confirm that:

• Aspirin reduces graft failure and major adverse cardiovascular events after CABG 3
• Early aspirin therapy is essential for maintaining graft patency 2, 4
• The benefits of aspirin continuation far outweigh bleeding risks in patients with established coronary artery disease 4

Clinical Algorithm

For routine diagnostic colonoscopy after CABG:

1. Continue aspirin at your current dose (81-325 mg daily) 1
2. No dose adjustment needed 1
3. No bridging therapy required 1
4. Proceed with colonoscopy as scheduled 1

If polyps are discovered during the procedure requiring polypectomy:

• Small polyps (<1 cm) can often be safely removed with aspirin continued, particularly using cold snare technique 1
• Larger polyps or extensive polypectomy may require discussion with your cardiologist about temporarily stopping aspirin, but this decision must weigh your high cardiac risk 1

Important Caveats

When Management Changes

The recommendation changes ONLY if your colonoscopy becomes a high-risk procedure (e.g., large polyp removal, EMR, ESD) 1. In such cases:

• Continue aspirin 1
• Liaise with a consultant interventional cardiologist about the risk/benefit of any antiplatelet modification 1
• Given your recent CABG, the thrombotic risk likely outweighs bleeding risk even for therapeutic interventions 1

Post-Procedure Monitoring

You should be counseled that there is an increased risk of post-procedure hemorrhage compared with patients not on antiplatelet drugs, though this risk remains low for diagnostic procedures 1. Watch for signs of GI bleeding (black stools, rectal bleeding, lightheadedness) and seek immediate care if these occur 1.

Common Practice Pitfalls

Despite clear guideline recommendations, a 2015 survey found that only 43.5% of U.S. endoscopy units routinely continue aspirin before colonoscopy 5. The most common reasons for inappropriate discontinuation were:

• Unfounded concern about bleeding after polypectomy (62%) 5
• Perceived minimal downside to stopping aspirin (38%) - this is incorrect for high-risk cardiac patients 5
• Inertia to changing old policies (20%) 5

These practices are not evidence-based and increase patient risk 5. Your gastroenterologist should follow current 2021 BSG/ESGE guidelines that strongly recommend aspirin continuation for diagnostic procedures 1.